These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22188926)

  • 1. A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor.
    Lane JR; Klein Herenbrink C; van Westen GJ; Spoorendonk JA; Hoffmann C; IJzerman AP
    Mol Pharmacol; 2012 Mar; 81(3):475-87. PubMed ID: 22188926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor.
    Lane JR; Klaasse E; Lin J; van Bruchem J; Beukers MW; Ijzerman AP
    Biochem Pharmacol; 2010 Oct; 80(8):1180-9. PubMed ID: 20599769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
    Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
    J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
    Piersen CE; True CD; Wells JN
    Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
    Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Roerink SF; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2005 Mar; 48(6):2045-53. PubMed ID: 15771447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Na
    Noël F; do Monte FM
    J Pharmacol Toxicol Methods; 2017; 84():51-56. PubMed ID: 27810394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
    Wang CD; Buck MA; Fraser CM
    Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation.
    Fresco P; Oliveira JM; Kunc F; Soares AS; Rocha-Pereira C; Gonçalves J; Diniz C
    Neurochem Int; 2007 Jul; 51(1):47-56. PubMed ID: 17493708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
    Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
    Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Insights into Partial Activation of the Prototypic G Protein-Coupled Adenosine A
    Claff T; Mahardhika AB; Vaaßen VJ; Schlegel JG; Vielmuth C; Weiße RH; Sträter N; Müller CE
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1415-1425. PubMed ID: 38751633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.
    Lebon G; Edwards PC; Leslie AG; Tate CG
    Mol Pharmacol; 2015 Jun; 87(6):907-15. PubMed ID: 25762024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.
    Fleck BA; Chen C; Yang W; Huntley R; Markison S; Nickolls SA; Foster AC; Hoare SR
    Biochemistry; 2005 Nov; 44(44):14494-508. PubMed ID: 16262250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
    Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
    Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
    Cunha RA; Constantino MD; Ribeiro JA
    Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.
    Kim SK; Gao ZG; Van Rompaey P; Gross AS; Chen A; Van Calenbergh S; Jacobson KA
    J Med Chem; 2003 Nov; 46(23):4847-59. PubMed ID: 14584936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.